by The global metagenomic sequencing market involves analysing genomes collected directly from environmental samples without isolating or culturing individual microbial species. Metagenomic sequencing technology aids in exploring microbial diversity, identifying novel genes and metabolites, monitoring interactions between microbes and their environment, diagnosing diseases by detecting pathogens, and characterizing microbiomes. It allows scientists to examine genetic material recovered directly from environmental samples containing diverse microbial populations. This helps uncover microorganisms that cannot be cultured in isolation in the laboratory. The technology has wide applications in healthcare, biotechnology, agriculture, and environmental management. It assists in developing new antibiotics and alternatives to traditional medicines by identifying novel genes from uncultured microbes.
The global metagenomic sequencing market was valued at US$ 1.41 Bn in 2023 and is expected to exhibit a CAGR of 17% over the forecast period 2023 to 2030, as highlighted in a new report published by CoherentMI.
Market Key Trends:
One of the key trends driving the global metagenomics sequencing market is the increasing research on human microbiome and its role in various diseases. Metagenomic sequencing has helped uncover links between microbes inhabiting human body and several ailments including metabolic disorders, intestinal bowel diseases, cancer, and neurological conditions. It has enabled scientists to study how changes in microbial diversity and interactions are linked to conditions like obesity, inflammatory bowel disease, diabetes, and autism. This is prompting further research funding and commercialization of microbiome-based diagnostics and therapies. The market is also witnessing increasing technological advancements like long-read sequencing platforms that provide longer sequencing reads for more comprehensive analysis of microbial communities and complex genomes.
Porter’s Analysis:
Threat of new entrants: The global metagenomic sequencing market requires high capital investment for R&D in developing new techniques and platforms. Additionally, the market is dominated by few major players creating barriers for new entrants.
Bargaining power of buyers: The demand for metagenomics sequencing is rising globally due to its wide applications in healthcare and industrial sectors, which increases the bargaining power of buyers.
Bargaining power of suppliers: Key suppliers for metagenomic sequencing include equipment manufacturers, sequencing platforms providers, and consumable suppliers. Their differentiated products provide them with high bargaining power.
Threat of new substitutes: Substitute technologies for metagenomic sequencing are still in nascent stage with limitations. No direct substitute is available currently, posing low threat from substitutes.
Competitive rivalry: The global market is characterized by high competition due to presence of many international and regional players. Players compete based on product innovation, quality, and pricing.
Global Metagenomic Sequencing Market Segmentation:
- By Technology:
- Sequencing
- Bioinformatics
- PCR
- Microarray
- Others
- By Product:
- Instruments
- Reagents & Consumables
- Services
- Analysis Softwares
- By Application
- Drug Discovery
- Disease Diagnosis
- Environmental Remediation
- Gut Microbe Characterization
- Others
- By End User:
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Agriculture & Biofuel Companies
- Hospitals & Clinics
- Others
Key Takeaways:
The Global Metagenomic Sequencing Market Size is expected to witness high growth over the forecast period supported by increasing R&D investments by biopharmaceutical and industrial companies. The global metagenomic sequencing market is estimated to be valued at US$ 1.41 Bn in 2023 and is expected to exhibit a CAGR of 17% over the forecast period 2023 to 2030.
Regional Analysis:
North America region is expected to dominate the global market owing to rising healthcare expenditure and presence of leading market players in the US and Canada. The Asia Pacific market is anticipated to grow at fastest CAGR during the forecast period with increasing governmental investments in life science research in China, India, and Japan.
Key Players:
Key players operating in the global metagenomic sequencing market are Illumina, QIAGEN, Thermo Fisher Scientific, Oxford Nanopore Technologies, BGI Group, PerkinElmer, GENEWIZ, Macrogen, Zymo Research, Diversigen, Microsynth AG, BaseClear, MR DNA (Molecular Research), Eurofins Scientific, Novogene Corporation, NuGEN Technologies, Takara Bio, Swift Biosciences, New England Biolabs, and CosmosID.
*Note:
1. Source: CoherentMI, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc.
